Alzheimer Disease Clinical Trial
Official title:
An Innovative Psychosocial Intervention for Adult-Child Caregivers of Parents With Alzheimer's Disease
The goal of this project is to test an intervention designed to reduce the incidence and magnitude of the negative effects, specifically stress, anxiety, and depression, frequently experienced by adult children who are caregivers of a parent with Alzheimer's disease (AD).
Caring for an elderly parent is a growing societal problem, and many studies have shown that
caring for a person with dementia can have a negative impact on a caregiver's psychological
and physical health, social life and career, and relationship with the patient. Stress and
coping models proposed in the AD caregiving literature, and general stress and coping
theories suggest that by improving caregivers' ability to cope and master the caregiving
situation, it is possible to avoid or ameliorate the negative emotional consequences of
caregiving.
Building upon the results of a pilot study, this study will formally test the efficacy of a
psychosocial intervention, based on a concept of caregiving that builds on the interests,
activities, and responsibilities of both the caregiver and patient in creating a care
strategy. The intervention is designed to reduce the negative effects frequently experienced
by adult children who care for a parent in the middle stage of Alzheimer's disease.
Caregivers will learn to engage with their parents in activities that are within the
patients' remaining functional and cognitive abilities. Caregivers will also be encouraged
to teach activities to other family members and paid caregivers. The study will also
evaluate a lower level of intervention, based on written materials.
It is expected that by increasing knowledge about AD and providing what may be a new
conceptual approach to relating to a parent at this point in the disease process, 1)
caregivers and patients may experience a higher level of satisfaction and gratification from
their interactions, 2) caregivers will gain a sense of control and mastery over a difficult
situation and thus feel more capable of coping and 3) the patient may maintain a higher
level of functioning.
A randomized treatment/control design will be used, and adult-child caregivers who
participate will be assigned to one of the two levels of intervention, each designed to
reduce stress, anxiety and depression. The benefits of each intervention will be evaluated
by looking at the change in scores on widely used measures of the anticipated outcomes among
caregivers in each group, and their relative benefits will be tested by comparing scores of
the caregivers in the two groups at two follow-up points, six and nine months after
baseline.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator)
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04044495 -
Sleep, Rhythms and Risk of Alzheimer's Disease
|
N/A | |
Completed |
NCT04079803 -
PTI-125 for Mild-to-moderate Alzheimer's Disease Patients
|
Phase 2 | |
Terminated |
NCT03052712 -
Validation and Standardization of a Battery Evaluation of the Socio-emotional Functions in Various Neurological Pathologies
|
N/A | |
Recruiting |
NCT04520698 -
Utilizing Palliative Leaders In Facilities to Transform Care for Alzheimer's Disease
|
N/A | |
Active, not recruiting |
NCT04606420 -
Can Lifestyle Changes Reverse Early-Stage Alzheimer's Disease
|
N/A | |
Recruiting |
NCT05820919 -
Enhancing Sleep Quality for Nursing Home Residents With Dementia - R33 Phase
|
N/A | |
Terminated |
NCT03672474 -
REGEnLIFE RGn530 - Feasibility Pilot
|
N/A | |
Completed |
NCT03430648 -
Is Tau Protein Linked to Mobility Function?
|
||
Recruiting |
NCT04522739 -
Spironolactone Safety in African Americans With Mild Cognitive Impairment and Early Alzheimer's Disease
|
Phase 4 | |
Recruiting |
NCT05557409 -
A Study to Assess the Efficacy and Safety of AXS-05 in Subjects With Alzheimer's Disease Agitation
|
Phase 3 | |
Recruiting |
NCT05288842 -
Tanycytes in Alzheimer's Disease and Frontotemporal Dementia
|
||
Recruiting |
NCT04949750 -
Efficacy of Paper-based Cognitive Training in Vietnamese Patients With Early Alzheimer's Disease
|
N/A | |
Completed |
NCT06194552 -
A Multiple Dose Study of the Safety and Pharmacokinetics of NTRX-07
|
Phase 1 | |
Completed |
NCT03239561 -
Evaluation of Tau Protein in the Brain of Participants With Alzheimer's Disease Compared to Healthy Participants
|
Early Phase 1 | |
Completed |
NCT03184467 -
Clinical Trial to Evaluate the Efficacy and Safety of GV1001 in Alzheimer Patients
|
Phase 2 | |
Active, not recruiting |
NCT03676881 -
Longitudinal Validation of a Computerized Cognitive Battery (Cognigram) in the Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease
|
||
Terminated |
NCT03487380 -
Taxonomic and Functional Composition of the Intestinal Microbiome: a Predictor of Rapid Cognitive Decline in Patients With Alzheimer's Disease
|
N/A | |
Completed |
NCT05538455 -
Investigating ProCare4Life Impact on Quality of Life of Elderly Subjects With Neurodegenerative Diseases
|
N/A | |
Recruiting |
NCT05328115 -
A Study on the Safety, Tolerability and Immunogenicity of ALZ-101 in Participants With Early Alzheimer's Disease
|
Phase 1 | |
Completed |
NCT05562583 -
SAGE-LEAF: Reducing Burden in Alzheimer's Disease Caregivers Through Positive Emotion Regulation and Virtual Support
|
N/A |